Abstract:Background: BRCA2-deficiency may confer cancer cells sensitivity to PARP inhibitors (PARPi) because of the compromised DNA homologous recombination (HR) repair. We previously reported AURKA suppressed BRCA2 expression to control HR. However, the exact mechanism is unclear.Methods: In vitro kinase assays and mass spectrometry were used to examine the phosphorylation of BRCA2 by AURKA. In vitro and in vivo experiments were performed to test the phosphorylation, polyubiquitination and tumorigenesis of wild-type or mutant BRCA2 stably expressing cells. Immunohistochemistry was used to determine the expression levels of p-BRCA2, BRCA2 and AURKA in ovarian cancer tissues.Finding: Using in vitro kinase assay and mass spectrum analysis, we show phosphorylation of BRCA2 at threonine 10 (T10) by AURKA promotes the interaction between BRCA2 and Skp2, which subsequently induces BRCA2 instability and nuclear ubiquitin-proteasome degradation, whereas the BRCA2-T10A mutant is unphosphorylated by AURKA, neither degraded by Skp2, but stabilized in nucleus. The non-degradable BRCA2-T10A enhances HR capacity via activation of ATM/Chk2 signaling to induce PARPi resistance. Moreover, SNP rs28897701 (A75P) and rs572782576 (L86P) mutants in BRCA2 interrupt phosphorylation of BRCA2 at T10 by AURKA and consequently induce PARPi resistance. Clinically, AURKA is positively correlated with cytoplasmic pBRCA2 (T10), but negatively correlated with nuclear BRCA2 in ovarian cancer.Interpretation: These data highlight phosphorylation of BRCA2 at T10 by AURKA may be a key event to mediate nuclear degradation and dysfunction of BRCA2, indicating a promising treatment strategy for ovarian cancer or other cancer types with PARPi.Funding Information: This work was supported by grants from the National Natural Science Foundation of China (81372797, 82002726, 81572553, 81772789 and 81402153) and the Clinical Postdoctoral Program of Physician Excellence (ZYJH202103).Declaration of Interests: The authors declare that they have no competing interests.Ethics Approval Statement: Research involved animal experiments was reviewed and approved by Fudan University Institutional Animal Care and Use Committee (2020 wuyuan JS-047). The implementation complies with the“International Ethical Standards Concerning Human 21 Research” stated in the “Helsinki Declaration”.

AurkA/TPX2 co-overexpression in nontransformed cells promotes genome instability through induction of chromosome mis-segregation and attenuation of the p53 signalling pathway

Contribution of AurkA/TPX2 Overexpression to Chromosomal Imbalances and Cancer

Aurora A Is Essential for Early Embryonic Development and Tumor Suppression

The negative interplay between Aurora A/B and BRCA1/2 controls cancer cell growth and tumorigenesis via distinct regulation of cell cycle progression, cytokinesis, and tetraploidy

Aurora-A Promotes the Establishment of Spindle Assembly Checkpoint by Priming the Haspin-Aurora-B Feedback Loop in Late G2 Phase

Aurora-A Interacts with Cyclin B1 and Enhances Its Stability.

Mitotic kinases: the key to duplication, segregation, and cytokinesis errors, chromosomal instability, and oncogenesis

High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability

Research progress on the relationship between AURKA and tumorigenesis: the neglected nuclear function of AURKA

Akt-Mediated Phosphorylation of XLF Impairs Non-Homologous End-Joining DNA Repair

Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation

An Aurora kinase A-BOD1L1-PP2A B56 Axis promotes chromosome segregation fidelity

Cdk1-phosphorylated CUEDC2 Promotes Spindle Checkpoint Inactivation and Chromosomal Instability.

Aurora B inhibition promotes a hyper-polyploid state and continued endomitotic cycles in RB and p53 defective cells

A p62-dependent rheostat dictates micronuclei catastrophe and chromosome rearrangements

Aurora-A Interacts With Ap-2 Alpha And Down Regulates Its Transcription Activity

Aurora Kinase a Phosphorylates BRCA2 to Promote Cell Sensitivity to PARP Inhibition

Crosstalk between Aurora-A and p53: frequent deletion or downregulation of Aurora-A in tumors from p53 null mice.

PTEN as an apologist of chromosomes from the aggressor cancer: mechanisms of chromosomal instability and prevention of aneuploidy

Roles Of Aurora Kinases In Mitosis And Tumorigenesis

Gain of function mutant p53 proteins cooperate with E2F4 to transcriptionally downregulate RAD17 and BRCA1 gene expression